2021-01-12 from cbc.ca

In the initial sprint to create a vaccine for COVID-19, Pfizer and Moderna crossed the finish line first. But for Canadian researchers who continue to work away at coronavirus vaccines and therapeutics, there are still big potential wins ahead.

While priority groups are already being inoculated against the virus thanks to vaccine shipments arriving from Europe, researchers like Volker Gerdts, CEO of Saskatoon's Vaccine and Infectious Disease Organization (VIDO), have their sights set on Canada's long game.

"It is important for us, for Canadians, to have long-term access to made-in-Canada vaccines," he said.

Read more here.